SCHEMBL25632099

SCHEMBL25632099

CC(=O)OC[C@H]1O[C@H](OC2=C(C)OC(=C(C)C)C2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.54
▸ THRB P10828 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ P4HB P07237 1/20 0.53
▸ PDIA4 P13667 1/20 0.53
▸ PDIA3 P30101 1/20 0.53
▸ TSHR P16473 1/20 0.47
▸ CA2 P00918 3/20 0.47
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA4 P22748 2/20 0.47
▸ CA5A P35218 2/20 0.47
▸ CA7 P43166 2/20 0.47
▸ CA5B Q9Y2D0 2/20 0.47
▸ PTPN1 P18031 1/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23552395 1.00 CYP2D6 (0.54) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552378 1.00 CYP2D6 (0.54) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL25632252 0.91 P4HB (0.46) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552404 0.89 P4HB (0.44) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552311 0.85 P4HB (0.40) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552312 0.83 P4HB (0.48) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552259 0.83 P4HB (0.48) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552464 0.82 P4HB (0.47) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552427 0.81 P4HB (0.47) CYP2D6THRBHSD17B10P4HBPDIA4
SCHEMBL23552405 0.81 CA12 (0.39) CYP2D6THRBHSD17B10P4HBPDIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FUDAN UNIVERSITY (CN) 2023-06-13 — — US disclosed
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FUDAN UNIVERSITY (CN) 2023-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11673909-B2 Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof FAR1, CYP4A11, SFRP1 CYP2D6 453/4885THRB 4838/4885HSD17B10 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback